PD-1/PD-L1 interaction also leads to selective suppression of tumor-specific T-cells, since PD-1 is expressed on T-cells upon activation after encountering tumor antigen, thereby forming a “molecular shield” allowing the tumor to evade immune response [7, 22]. The gene discussed is CD274; the disease is neoplasm.